Interferon-λ in HCV Infection and Therapy Por Michael D. Robek, Nicole E. Pagliaccetti

Obter o texto integral

Epigenetic reprogramming of the type III interferon response potentiates antiviral activity and suppresses tumor growth. Por Siyuan Ding, William Khoury-Hanold, Akiko Iwasaki, Michael D Robek

Obter o texto integral

Virus-based vaccine vectors with distinct replication mechanisms differentially infect and activate dendritic cells Por Carolina Chiale, Anthony M. Marchese, Yoichi Furuya, Michael D. Robek

Obter o texto integral

Functional characterization of the putative hepatitis B virus core protein late domain using retrovirus chimeras. Por Mayra L Garcia, Tracy D Reynolds, Walther Mothes, Michael D Robek

Obter o texto integral

CD4+ T cells reverse surface antigen persistence in a mouse model of HBV replication Por Jacob T. Bailey, Safiehkhatoon Moshkani, Catherine Rexhouse, Jesse L. Cimino, Michael D. Robek

Obter o texto integral

Modified Alphavirus-Vesiculovirus Hybrid Vaccine Vectors for Homologous Prime-Boost Immunotherapy of Chronic Hepatitis B Por Carolina Chiale, Timur O. Yarovinsky, Stephen W. Mason, Bhaskara R. Madina, Manisha Menon, Marie M. Krady, Safiehkhatoon Moshkani, Anasuya Chattopadhyay Pal, Bijan Almassian, John K. Rose, Michael D. Robek, Valerian Nakaar

Obter o texto integral

Virus-like Vesicles Expressing Multiple Antigens for Immunotherapy of Chronic Hepatitis B Por Timur O. Yarovinsky, Stephen W. Mason, Manisha Menon, Marie M. Krady, Maria Haslip, Bhaskara R. Madina, Xianyong Ma, Safiehkhatoon Moshkani, Carolina Chiale, Anasuya Chattopadhyay Pal, Bijan Almassian, John K. Rose, Michael D. Robek, Valerian Nakaar

Obter o texto integral